Chronic Obstructive Pulmonary Disease clinical trials at UC Davis
2 research studies open to eligible people
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
“Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!”
open to eligible people ages 40-84
The objective of this study is to assess the safety and efficacy of Apreo BREATHE system when used to support native airways and release trapped air in the treatment of adult COPD patients with emphysema suffering from dyspnea due to hyperinflation despite optimal medical treatment. The Apreo BREATHE Airway Scaffold is a permanent implant designed to tent open native airways. The study will include up to 250 participants at up to 25 study centers located in the United States and Europe. Study subjects will be followed for 3 years. The main questions it aims to answer are: Is it safe? Does it work?
Sacramento, California and other locations
Long-term, Open-label Study of SAR447537 (INBRX-101) in Adults With Alpha-1 Antitrypsin Deficiency Emphysema
“Alpha 1 Antitrypsin Deficiency Infusion Trial”
open to eligible people ages 18-80
Phase 2 open label extension study to evaluate SAR447537 (INBRX-101) in adults with AATD emphysema
Sacramento, California and other locations
Our lead scientists for Chronic Obstructive Pulmonary Disease research studies include Chinh Phan, DO.
Last updated: